Solution uses fully automated AI segmentation to generate inHEART’s digital twin of the heart with greater speed and efficiency
The soft tissue robotics leader incorporated new features into the system, from tissue sensing feedback to a smaller size and more comfortable console.
Inspectors found fault with the handling of corrective and preventive actions for the Ivenix Infusion System.
Axonics (Nasdaq:AXNX) announced today that it received CE mark approval for its R20 rechargeable sacral neuromodulation (SNM) system.
SafeGuard Surgical announced today that the FDA granted breakthrough device designation to its LeakGuard biodegradable stent.
SetPoint Medical announced today that received FDA breakthrough device designation for its novel neuroimmune modulation platform.
The collaborators aim to resolve the clinical, regulatory, coverage and payment questions facing developers of the devices.
Onward Medical announced today that the FDA accepted it into its new Total Product Lifecycle Advisory Program (TAP) — a move that could boost the development of Onward’s BCI technology.
Pulse Biosciences (Nasdaq:PLSE) announced that the FDA granted 510(k) clearance for its CellFX nsPFA percutaneous electrode system.
One panelist who voted yes said the “incremental benefits outweigh the small risks of anaphylaxis.”